Data as of Mar 14
| -0.09 / -0.16%|
The 17 analysts offering 12-month price forecasts for Merck & Co Inc have a median target of 57.00, with a high estimate of 64.00 and a low estimate of 44.00. The median estimate represents a +2.33% increase from the last price of 55.70.
The current consensus among 21 polled investment analysts is to Hold stock in Merck & Co Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.